Citations 17

SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19

Current Medicinal Chemistry | March 31, 2023 | Volume: 30 | Issue: 39 | Pages: 4390-4408

10.2174/0929867330666230330092725 | PMID 36998130

Abstract: The COVID-19 pandemic, caused by the coronavirus, SARS-CoV-2, has claimed millions of lives worldwide in the past two years. Fatalities among the elderly with underlying cardiovascular disease, lung disease, and diabetes have particularly been high. A biometrics analysis on author’s keywords was carried out, and searched for possible links between various coronavirus studies over the past 50 years, and integrated them. We found keywords like immune system, immunity, nutrition, malnutrition, micronutrients, exercise, inflammation, and hyperinflammation were highly related to each other. Based on these findings, we hypothesized that the human immune system is a multilevel super complex system, which employs multiple strategies to contain microorganism infections and restore homeostasis. It was also found that the behavior of the immune system is not able to be described by a single immunological theory. However, one main strategy is “self-destroy and rebuild”, which consists of a series of inflammatory responses: 1) active self-destruction of damaged/dysfunctional somatic cells; 2) removal of debris and cells; 3) rebuilding tissues. Thus, invading microorganisms’ clearance could be only a passive bystander response to this destroy–rebuild process. Microbial infections could be self-limiting and promoted as an indispensable essential nutrition for the vast number of genes existing in the microorganisms. The transient nutrition surge resulting from the degradation of the self-destroyed cell debris coupled with the existing nutrition state in the patient may play an important role in the pathogenesis of COVID-19. Finally, a possible coping strategies to mitigate COVID-19, including vaccination is also discussed.
A Collaborative Approach to Treatment Strategies for Latent Tuberculosis Infection

Preventing Chronic Disease | June 26, 2020 | Volume: 17 | Issue: No issue available | Pages: No page available

10.5888/pcd17.200124 | PMID 32614769

Re: From the frontlines of COVID–19—how prepared are we as obstetricians? A commentary

BJOG: An International Journal of Obstetrics & Gynaecology | May 6, 2020 | Volume: 127 | Issue: 8 | Pages: 1041-1041

10.1111/1471-0528.16257 | PMID 32372542

Reporting of all cardiac medications and their outcome in COVID‐19

Journal of Medical Virology | April 8, 2020 | Volume: 92 | Issue: 9 | Pages: 1419-1420

10.1002/jmv.25843 | PMID 32266993

Patterns of heart injury in COVID‐19 and relation to outcome

Journal of Medical Virology | April 8, 2020 | Volume: 92 | Issue: 10 | Pages: 1747-1747

10.1002/jmv.25847 | PMID 32267000

A twin challenge to handle: COVID‐19 with pregnancy

Journal of Medical Virology | April 5, 2020 | Volume: 92 | Issue: 10 | Pages: 1718-1720

10.1002/jmv.25784 | PMID 32248565

COIVD-19 disease: tackling a pandemic in 21st century

QJM: An International Journal of Medicine | April 2, 2020 | Volume: 113 | Issue: 7 | Pages: 519-520

10.1093/qjmed/hcaa117 | PMID 32267941

Latest updates on COVID‐2019: A changing paradigm shift

Journal of Medical Virology | March 20, 2020 | Volume: 92 | Issue: 6 | Pages: 533-535

10.1002/jmv.25760 | PMID 32196703

COVID‐2019 and pregnancy: A plea for transparent reporting of all cases

Acta Obstetricia et Gynecologica Scandinavica | March 19, 2020 | Volume: 99 | Issue: 7 | Pages: 951-951

10.1111/aogs.13850 | PMID 32191350

Stroke Symptoms in a Patient on 4-Factor Prothrombin Complex

Hospital Pharmacy | March 2, 2020 | Volume: 56 | Issue: 5 | Pages: 413-414

10.1177/0018578720910395 | PMID 34720138